Ir para o conteúdo principal

United States News Todas as matérias

Todas as matérias desta seção, das mais recentes às mais antigas — página 292 de 371.

Grafa
Health

Zimmer Biomet beats estimates but cautious 2026 guidance weighs on shares

Zimmer Biomet Holdings (NYSE:ZBH) reported fourth-quarter results on Tuesday, February 10, 2026, that exceeded Wall Street expectations, though the medical device giant’s shares remained under pressure following a "cautious" outlook for the coming fiscal year.

Leia mais: Zimmer Biomet beats estimates but cautious 2026 guidance weighs on shares
Grafa
Technology

Sequans posts record loss on Bitcoin impairment while signaling 2026 turnaround

Sequans Communications (NYSE: SQNS) released unaudited fourth-quarter and full-year 2025 financial results on Tuesday, February 10, 2026, revealing a complex balance sheet shaped by its pioneering—and volatile—Bitcoin treasury strategy.

Leia mais: Sequans posts record loss on Bitcoin impairment while signaling 2026 turnaround
Grafa
Technology

Meta wins procedural victory as EU high court revives WhatsApp fine appeal

The European Court of Justice (ECJ) ruled on Tuesday, February 10, 2026, that WhatsApp Ireland’s legal challenge against the European Data Protection Board (EDPB) is admissible, breathing new life into a five-year battle over a €225 million ($268 million) privacy fine.

Leia mais: Meta wins procedural victory as EU high court revives WhatsApp fine appeal
Grafa

Honda operating profit plunges 61% as U.S. tariffs and EV slowdown hit results

Honda Motor (NYSE:HMC) reported on Tuesday, February 10, 2026, that its fiscal third-quarter operating profit tumbled 61.4% as the company navigates a perfect storm of U.S. trade tariffs and a costly pivot in its electric vehicle strategy.

Leia mais: Honda operating profit plunges 61% as U.S. tariffs and EV slowdown hit results
Grafa
Oil and Gas

BP suspends buybacks as $4B impairment triggers heavy quarterly loss

BP (NYSE:BP) reported a substantial fourth-quarter net loss of $3.42 billion on Tuesday, as the British energy major took a massive $4.3 billion post-tax impairment charge primarily linked to its "transition businesses" in the gas and low-carbon energy segments.

Leia mais: BP suspends buybacks as $4B impairment triggers heavy quarterly loss
Grafa
Health

AstraZeneca misses estimates as higher R&D spending offsets oncology growth

AstraZeneca (NASDAQ:AZN) reported fourth-quarter and full-year 2025 results on Tuesday that failed to meet Wall Street’s expectations, as a surge in operating costs for its expanding drug pipeline dampened the impact of double-digit sales growth in its oncology division.

Leia mais: AstraZeneca misses estimates as higher R&D spending offsets oncology growth
Grafa
Technology

ASE Technology revenue jumps as AI supercycle accelerates packaging demand

Taipei, Taiwan-based ASE Technology Holding (NYSE:ASX), a leading provider of semiconductor packaging, assembly, testing, and materials services, reported unaudited consolidated net revenues for January 2026 to meet Taiwan regulatory requirements.

Leia mais: ASE Technology revenue jumps as AI supercycle accelerates packaging demand
Grafa
Health

Biofrontera surges as Ameluz hits primary endpoint in critical Phase 3 AK trial

Biofrontera (NASDAQ:BFRI) has achieved a significant clinical milestone, announcing that its Phase 3 trial of Ameluz® photodynamic therapy (PDT) met its primary endpoint for the treatment of mild-to-moderate actinic keratoses (AK) located on the extremities, neck, and trunk.

Leia mais: Biofrontera surges as Ameluz hits primary endpoint in critical Phase 3 AK trial